| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Veru Inc. (VERU) has 8 insiders with recent SEC Form 4 filings, including 13 buys and 0 sells. VERU is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 100.0K | $231.0K | - | |
| CEO | 100.0K | $231.0K | - | |
| Other | 27.0K | $62.4K | - | |
| Other | 27.0K | $62.4K | - | |
| CFO | 27.0K | $62.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2017 | Haines Daniel | Chief Financial Officer | Buy | 10,000 | $1.10 | $11,000.00 | +14.7% | |
| May 30, 2017 | Fisch Harry | Director, 10% Owner | Buy | 12,000 | $1.27 | $15,202.80 | +34.5% | |
| May 24, 2017 | Fisch Harry | Director, 10% Owner | Buy | 10,000 | $1.10 | $11,000.00 | +40.4% | |
| May 22, 2017 | Fisch Harry | Director, 10% Owner | Buy | 24,750 | $1.02 | $25,262.15 | +495.0% | |
| May 17, 2017 | Haines Daniel | Chief Financial Officer | Buy | 5,000 | $1.01 | $5,047.50 | +7.9% | |
| May 15, 2017 | Haines Daniel | Chief Financial Officer | Buy | 5,000 | $1.03 | $5,131.50 | +8.6% | |
| May 15, 2017 | Bethune David R | Director | Buy | 10,000 | $1.03 | $10,305.00 | +2.3% | |
| May 15, 2017 | Parrish O B | Director | Buy | 20,000 | $1.02 | $20,390.00 | +1.2% | |
| May 12, 2017 | Bethune David R | Director | Buy | 20,000 | $1.03 | $20,577.00 | +2.4% | |
| May 11, 2017 | Lu Lucy | Director | Buy | 5,000 | $1.00 | $5,000.00 | New |